Prague, Czechia

Petr Simon

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Petr Simon: A Pioneer in Quinazoline Compounds

Introduction

Petr Simon, an accomplished inventor based in Prague, CZ, has made significant contributions to the field of medicinal chemistry. With a total of four patents to his name, Simon is recognized for his innovative work on quinazoline compounds, which hold promise in various pharmaceutical applications.

Latest Patents

Among Simon's most recent patents are his groundbreaking developments in quinazoline compounds. These patents describe compounds of Formula (I) and their tautomers and pharmaceutical salts. Additionally, they detail compositions and formulations containing such compounds, as well as the methods for their use and production. The potential applications of these compounds could lead to advancements in treatment methodologies and pharmaceutical formulations.

Career Highlights

Throughout his career, Petr Simon has collaborated with some prominent organizations, including Gilead Sciences, Inc. and the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (AS CR, v.v.i.). His experience in these institutions has enabled him to develop and refine his innovations, ensuring they meet the highest scientific and medical standards.

Collaborations

Simon has worked alongside notable colleagues, including Ondrej Baszczynski and Milan Dejmek. Their partnership has fostered a collaborative environment that promotes creativity and progress in research, enhancing the impact of Simon's inventions on the field of organic chemistry.

Conclusion

Petr Simon's dedication to advancing the science of quinazoline compounds marks him as a leading figure in medicinal chemistry. His patents not only reflect his innovative spirit but also contribute to the broader landscape of pharmaceutical research. As he continues to explore new horizons in his field, the potential for impactful discoveries remains vast.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…